- Exchange: London
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Snapshot for Abcam PLC (ABC)
| Open: | 455.250 | Day's Range: | 448.250 - 455.250 | Volume: | 89,960 |
|---|---|---|---|---|---|
| Previous Close: | 450.000 | 52wk Range: | 352.500 - 474.500 | 1-Yr Rtn: | +20.61% |
Key Statistics for ABC
| Current P/E Ratio (ttm) | 31.4542 |
|---|---|
| Estimated P/E(06/2013) | 26.4706 |
| Relative P/E vs. UKX | 1.8366 |
| Earnings Per Share (GBP) (ttm) | 0.1431 |
| Est. EPS (GBP) (06/2013) | 0.1700 |
| Est. PEG Ratio | - |
| Market Cap (M GBP) | 896.96 |
| Shares Outstanding (M) | 199.33 |
| 30 Day Average Volume | 274,988 |
| Price/Book (mrq) | 5.7759 |
| Price/Sale (ttm) | 7.8604 |
| Dividend Indicated Gross Yield | 1.56% |
| Cash Dividend (GBp) | 1.9400 |
| Last Dividend | 03/20/2013 |
| 5 Year Dividend Growth | 49.41% |
| Next Earnings Announcement | 09/06/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for ABC
Company Profile & Key Executives for ABC
Abcam PLC produces and distributes research-grade antibodies via an online catalog. The Company's customers include universities, research institutes, and pharmaceutical and biotechnology companies in countries around the world.
| Jonathan MilnerCEO/Co-Founder | Jeff IliffeCFO/Secretary |
| Jim WarwickChief Operating Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
ABC News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page